Brainsway (BRSYF) Amortizatization of Intangibles (2018 - 2024)
Brainsway's (BRSYF) quarterly Amortizatization of Intangibles came in at -$190000.0 in Q1 2024, up 86.5% on a YoY basis from -$101878.8 in Q2 2023, and down 185.97% quarter-over-quarter from $221000.0 in Q4 2023.
Powered by 
Analysis
Brainsway (BRSYF) Amortizatization of Intangibles (2018 - 2024) Analysis & Trends
Brainsway (BRSYF) has reported Amortizatization of Intangibles for 7 consecutive years, with -$190000.0 the latest figure, recorded in Q1 2024.
- For the quarter ending Q1 2024, Amortizatization of Intangibles rose 86.5% year-over-year to -$190000.0; the trailing twelve-month figure through Mar 2024 stood at -$1.2 million (up 14.71% YoY), and the FY2023 full-year result was -$1.0 million, down 388.6% from the prior year.
- Amortizatization of Intangibles eased to -$190000.0 in Q1 2024 per BRSYF's latest filing, from $221000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $412000.0 in Q1 2021 and bottomed at -$1.4 million in Q1 2023.
- Historically, Amortizatization of Intangibles has averaged $74500.0 across 5 years, with a median of $230000.0 in 2020.
- The widest YoY moves for Amortizatization of Intangibles: up 155.11% in 2023, down 534.26% in 2023.
- Over 5 years, Amortizatization of Intangibles stood at $239000.0 in 2020, then soared by 58.58% to $379000.0 in 2021, then plunged by 205.8% to -$401000.0 in 2022, then soared by 155.11% to $221000.0 in 2023, then slumped by 185.97% to -$190000.0 in 2024.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered -$190000.0, $221000.0, and $199000.0 for Q1 2024, Q4 2023, and Q2 2023 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.78 Bn | 175.17 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.04 Bn | 121.82 Bn | 1.96 Bn | 38.80 Mn |
| 3 | Medtronic | 117.04 Bn | 108.22 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.86 Bn | 100.38 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.74 Bn | 45.49 Bn | 1.35 Bn | 6.60 Mn |
| 7 | Alcon | 32.99 Bn | 31.53 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.12 Bn | 30.17 Bn | 830.00 Mn | - |
| 9 | Steris | 20.69 Bn | 20.21 Bn | 684.20 Mn | - |
| 10 | Brainsway | 592.58 Mn | 529.41 Mn | 12.77 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2024 | -190,000.00 |
| Dec 31, 2023 | 221,000.00 |
| Jun 30, 2023 | 199,000.00 |
| Mar 31, 2023 | -1.41 Mn |
| Dec 31, 2022 | -401,000.00 |
| Sep 30, 2022 | 99,000.00 |
| Jun 30, 2022 | 329,000.00 |
| Mar 31, 2022 | 324,000.00 |
| Dec 31, 2021 | 379,000.00 |
| Sep 30, 2021 | 360,000.00 |
| Jun 30, 2021 | 269,000.00 |
| Mar 31, 2021 | 412,000.00 |
| Dec 31, 2020 | 239,000.00 |
| Sep 30, 2020 | 210,000.00 |
| Dec 31, 2019 | 178,000.00 |
| Sep 30, 2019 | 344,000.00 |
| Jun 30, 2019 | 672,000.00 |
| Dec 31, 2018 | 323,000.00 |
| Sep 30, 2018 | 508,000.00 |
| Jun 30, 2018 | 741,000.00 |